Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-19

FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MICARDIS (telmisartan) submitted by Boehringer Ingelheim Pharmaceuticals, expanding the labeling for the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)

Snippet

SUPPL AP for MICARDIS (TELMISARTAN)